Under the leadership of Co-Founder and CEO Tim Blair, ICHOR Vascular Inc. is advancing a new approach to treating peripheral vascular occlusions by converting one...
Author: iCHOR
Thrombectomy Opportunities in Peripheral Artery and Vein Sub-markets
Executive Summary for Investors and Strategic Partners The perception that thrombectomy is “crowded” often stems from evaluating the category in aggregate rather than by addressable...
Is the Thrombectomy Market REALLY Overcrowded?
“Thrombectomy” is frequently treated as a single, monolithic category, leading to the misconception that there are too many devices and not enough room to stand...
